Deciphera Pharmaceuticals shares are trading higher after Stifel upgraded the stock from Hold to Buy.
Portfolio Pulse from Benzinga Newsdesk
Deciphera Pharmaceuticals' shares are trading higher following an upgrade from Stifel, which changed its rating from 'Hold' to 'Buy'.
August 10, 2023 | 4:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deciphera Pharmaceuticals' stock is trading higher after Stifel upgraded the stock from Hold to Buy.
The upgrade from Stifel is a positive signal for investors, indicating increased confidence in the company's performance. This has led to an increase in the trading price of Deciphera Pharmaceuticals' shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100